Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AQUAVAN vs Midazolam for Sedation in Colonoscopy
NCT00209573Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Sep 2004
- Modality
- Prodrugs/Conditional Activator Small Molecules
01
Overview
Phase 3, randomised, open-label trial of fospropofol disodium (2 arms), sponsored by Eisai Co., Ltd. Primary endpoint: Sedation Success Rate. Started Sep 2004; status: completed.
02
Drugs
fospropofol disodium
Beyond the preview
Go deeper on NCT00209573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00209573.